| Select | Gene | Cds | Cds_length | GC_content | Pep | Pep_length |
|---|---|---|---|---|---|---|
| Pvu9g1645 | ATGCAAGTTTCCTCCTCCTGGTTCGGTACCTTACCTTGTTCACTTCCTCTGGAATCCTGTTCCACCTCAACCACATGCCTTTCCGCTTCCTCCTACACCTATTCTCCTCGTACTAACGTCTTTTTCACGCGCTCTCATCCACGACCCTTCACTGCTCTCTCGTTTCTGGTCTCTCAAAGAAAAGGCTTCACGCAGTTGGCACCGATCAGAAGGTCCAAGAAGAGAAGAAGAGCGTTGGGTGTTTCCGCTGTGTTCGAACGCTTCACGGAAAGAGCAATAAAAGCCATAGTCTTGTCGCAGAGGGAAGCCAAAGGGCTCGGAAGCGAATTGGTTTACACGCAACATCTCTTGCTGGGACTTGTGGCAGAGGAGGATCGCTCCTCCGACGGTTTTCTCGCGTCTGGTATCCCGGTCGAGAAGGCACGTGAGGTTGTTCGCAATATCTGGCATCGGAACAGTTCTGCACGTGGTGGGGTCAATGATGATCACAAAACAAGTGCCACGCAGGTTCCCTTTTCCGTTAATGCGAAGCGAGTGTTTGAGGCTGCGGTGGAGTATTCGAAGTCTCTGGGACACAAATTCGTTGCCCCGGAACACATTACTGTGGGTTTAGTCAAAGTGGATGATGGAAGTGTTAGTAGGATTCTTTACAGATTGGGGACAAATGGAAATCAATTGGCAGCTGTGGCATTCTCCAGATTACAAAAGGAGATTGCTAAAGACGGTAGAGAACCTAACACAGTGTCCAAGGGGATTCCTAACAAATCGCTTTCTAGAAAAGGTTCTGAAGCTGGAGCCTCTGGCACAACAGGAGAGGAGAGTCCTTTATCACAATTTTGTGTGGATCTCACTGCCCGTGCAAGTGAAGGACAAATTGATCCAGTTGTTGGCCGAGAAGTTGAAGTTCAGAGAATAATTCAAATACTATGCAGGAAAACAAAAAGTAATCCCATTCTTCTTGGTGAAGCTGGAGTTGGAAAAACTGCTATTGCCGAGGGGTTGGCACTTCGTATTGCTAAGGCAGATGTTTCTCCCTTTTTATTGACAAAGCGTGTGATGTCCTTGGATATAGCCCTCTTAATGGCTGGAGCAAAAGAAAGAGGAGAGCTAGAGGAACGTGTTACAAAGTTGATAAAAGAAGTGATCAAGTCAGGTGATGTCATTCTCTTCATTGACGAAGTTCATATACTTGTTCAGGCAGGAACAGTTGGGAGAGGAAATAAGGGATCTGGCCTTGACATTGCTAATTTACTTAAACCTGCACTTGGAAGAGGTCAATTTCAGTGTATTGCATCAACCACCATAGATGAATACAGACTTTACTTTGAAAAAGACACAGCGTTGGCTCGACGGTTTCAACCTGTTTGGGTTGATGAGCCGAGTGAGGATGACGCGATTAAGATCCTTACGGGCATACGTGAGAAATATGAGGCATATCATAAATGCAGATACACAACAGATGCTATAAAGGCTGCAGTTGATTTGTCAGCAAGATACATAGTTGATAGGTATCTACCTGATAAAGCTATTGACCTCATAGATGAAGCAGGAAGCAGAGCTCGTATTGTAGCCTTTAAGAAGAAAAAGGAACAAGAAACTGGCATTCTTTCTAAGTGCCCAGCTGATTACTGGCAAGAAATTAGAGCGGTCAAGTCCATGCATGAAATGGAGAGCAAGCTTAAATACTATGGTGCTTCCAACATTGACGAAAACAATGAACTCATACTGGATTCATATTTATCTTCTACAACCATTGATGATGAACCAATAGTAGTGGGGCCAGAAGATATAGCAGCAGTTGCTTCCCTCTGGTCAGGAATTCCTGTGCAGAAGCTCACGGTTGATCAAAGAATTCTTCTGTTAGACCTTGATAATCAACTTCGCAAACGTGTGATTGGACAAGAGGAGGCTGTTGCTGCCATTTCTAGAGCTGTGAAGAGATCTCGGGTTGGCCTCAAGGATCCTGATAGACCAATAGCTACCTTGTTATTCTGTGGTCCTACCGGAGTTGGGAAAACAGAACTTGCAAAATCTTTGGCTGCATGTTACTTTGGATCGGAGGCAGCCATGGTACGACTAGACATGAGTGAATACATGGAACGGCATACAGTGAGCAAATTGATCGGATCACCCCCAGGTTATGTTGGTTATGGAGAGGGCGGCGTTTTAACTGAAGCTATTAGAAGAAAACCGTTTACTGTGTTATTGCTTGATGAAATAGAGAAAGCTCATCCAGATATATTCAACATTCTTCTTCAAATTTTGGAAGATGGTCAACTTACTGATTCTCAGGGTCGCAGAGTTTCATTTAAAAATGCACTGGTGGTAATGACTTCAAATGTGGGGTCTAGTGCAATTGCTAAGGGTCAACACAACTCCATAGGTTTCTTGATTCCTGATGATAAAACAACATCATACAATGGCTTGAAATCGATGGTAATTGAAGAACTAAGGACATATTTTCGTCCAGAATTGCTCAACAGGATAGATGAAGTGGTAGTGTTTCAACCCCTCGAGAAGTCACAGTTACTGAAGATATTGGATTTGCTTCTTCAAGACATGAAGAAAAGGGTGTTGTCCCTAGGAATCAATGTTAAGGTGTCTGAAGCAATGAAGAACCTTGTGTGCCAGCAAGGCTATAACCCAACATATGGTGCTAGGCCTCTGAGAAGGGCCATTACATCACTAATAGAAGATCCATTGAGTGAGGCATTTCTTTTTGGAGAATGCAAGCCAGGTGACACTGTCCTCATCGATTTGGATGCTAATGGTTACCCCTTTATTACAAATCAGTTTGATAAGATTGTCAACTTATCTGACTGA | 2823 | 0.4389 | MQVSSSWFGTLPCSLPLESCSTSTTCLSASSYTYSPRTNVFFTRSHPRPFTALSFLVSQRKGFTQLAPIRRSKKRRRALGVSAVFERFTERAIKAIVLSQREAKGLGSELVYTQHLLLGLVAEEDRSSDGFLASGIPVEKAREVVRNIWHRNSSARGGVNDDHKTSATQVPFSVNAKRVFEAAVEYSKSLGHKFVAPEHITVGLVKVDDGSVSRILYRLGTNGNQLAAVAFSRLQKEIAKDGREPNTVSKGIPNKSLSRKGSEAGASGTTGEESPLSQFCVDLTARASEGQIDPVVGREVEVQRIIQILCRKTKSNPILLGEAGVGKTAIAEGLALRIAKADVSPFLLTKRVMSLDIALLMAGAKERGELEERVTKLIKEVIKSGDVILFIDEVHILVQAGTVGRGNKGSGLDIANLLKPALGRGQFQCIASTTIDEYRLYFEKDTALARRFQPVWVDEPSEDDAIKILTGIREKYEAYHKCRYTTDAIKAAVDLSARYIVDRYLPDKAIDLIDEAGSRARIVAFKKKKEQETGILSKCPADYWQEIRAVKSMHEMESKLKYYGASNIDENNELILDSYLSSTTIDDEPIVVGPEDIAAVASLWSGIPVQKLTVDQRILLLDLDNQLRKRVIGQEEAVAAISRAVKRSRVGLKDPDRPIATLLFCGPTGVGKTELAKSLAACYFGSEAAMVRLDMSEYMERHTVSKLIGSPPGYVGYGEGGVLTEAIRRKPFTVLLLDEIEKAHPDIFNILLQILEDGQLTDSQGRRVSFKNALVVMTSNVGSSAIAKGQHNSIGFLIPDDKTTSYNGLKSMVIEELRTYFRPELLNRIDEVVVFQPLEKSQLLKILDLLLQDMKKRVLSLGINVKVSEAMKNLVCQQGYNPTYGARPLRRAITSLIEDPLSEAFLFGECKPGDTVLIDLDANGYPFITNQFDKIVNLSD* | 941 |
| Select | Seq ID | Length | Analysis | Description | Start | End | IPR | GO |
|---|---|---|---|---|---|---|---|---|
| Pvu9g1645 | 940 | Pfam | Clp amino terminal domain, pathogenicity island component | 100 | 147 | IPR004176 | - | |
| Pvu9g1645 | 940 | Pfam | Clp amino terminal domain, pathogenicity island component | 183 | 227 | IPR004176 | - | |
| Pvu9g1645 | 940 | CDD | AAA | 632 | 780 | - | - | |
| Pvu9g1645 | 940 | Pfam | AAA domain (Cdc48 subfamily) | 657 | 832 | IPR003959 | GO:0005524|GO:0016887 | |
| Pvu9g1645 | 940 | PANTHER | CHAPERONE PROTEIN CLPD1, CHLOROPLASTIC | 65 | 940 | - | - | |
| Pvu9g1645 | 940 | SUPERFAMILY | P-loop containing nucleoside triphosphate hydrolases | 275 | 532 | IPR027417 | - | |
| Pvu9g1645 | 940 | MobiDBLite | consensus disorder prediction | 249 | 274 | - | - | |
| Pvu9g1645 | 940 | ProSitePatterns | Chaperonins clpA/B signature 2. | 692 | 710 | IPR028299 | - | |
| Pvu9g1645 | 940 | Pfam | AAA lid domain | 461 | 555 | IPR041546 | - | |
| Pvu9g1645 | 940 | Pfam | ATPase family associated with various cellular activities (AAA) | 318 | 425 | IPR003959 | GO:0005524|GO:0016887 | |
| Pvu9g1645 | 940 | ProSitePatterns | Chaperonins clpA/B signature 1. | 413 | 425 | IPR018368 | GO:0005524 | |
| Pvu9g1645 | 940 | Gene3D | - | 838 | 934 | - | - | |
| Pvu9g1645 | 940 | CDD | AAA | 296 | 453 | - | - | |
| Pvu9g1645 | 940 | Pfam | C-terminal, D2-small domain, of ClpB protein | 838 | 917 | IPR019489 | - | |
| Pvu9g1645 | 940 | Gene3D | UVR domain | 527 | 588 | - | - | |
| Pvu9g1645 | 940 | Gene3D | - | 266 | 461 | IPR027417 | - | |
| Pvu9g1645 | 940 | SMART | AAA_5 | 313 | 462 | IPR003593 | - | |
| Pvu9g1645 | 940 | SMART | AAA_5 | 658 | 839 | IPR003593 | - | |
| Pvu9g1645 | 940 | Gene3D | - | 87 | 244 | IPR036628 | - | |
| Pvu9g1645 | 940 | SUPERFAMILY | Double Clp-N motif | 86 | 230 | IPR036628 | - | |
| Pvu9g1645 | 940 | SUPERFAMILY | P-loop containing nucleoside triphosphate hydrolases | 607 | 922 | IPR027417 | - | |
| Pvu9g1645 | 940 | ProSiteProfiles | Clp repeat (R) domain profile. | 85 | 237 | IPR004176 | - | |
| Pvu9g1645 | 940 | PANTHER | CHAPERONE PROTEIN CLPD, CHLOROPLASTIC | 65 | 940 | - | - | |
| Pvu9g1645 | 940 | SMART | ClpB_D2_small_2 | 838 | 927 | IPR019489 | - | |
| Pvu9g1645 | 940 | Gene3D | - | 463 | 604 | - | - | |
| Pvu9g1645 | 940 | PRINTS | ATP-dependent Clp protease ATP-binding subunit signature | 662 | 680 | IPR001270 | GO:0005524 | |
| Pvu9g1645 | 940 | PRINTS | ATP-dependent Clp protease ATP-binding subunit signature | 707 | 725 | IPR001270 | GO:0005524 | |
| Pvu9g1645 | 940 | PRINTS | ATP-dependent Clp protease ATP-binding subunit signature | 736 | 754 | IPR001270 | GO:0005524 | |
| Pvu9g1645 | 940 | PRINTS | ATP-dependent Clp protease ATP-binding subunit signature | 769 | 783 | IPR001270 | GO:0005524 | |
| Pvu9g1645 | 940 | MobiDBLite | consensus disorder prediction | 242 | 274 | - | - | |
| Pvu9g1645 | 940 | Gene3D | - | 612 | 836 | IPR027417 | - |
| Select | Gene | Chromosome | Start | End | Duplicated_type |
|---|---|---|---|---|---|
| Pvu9g1645 | Pvu-Chr9 | 23102730 | 23109132 | Dispersed/Transposed |
| Select | Query | KO | Definition | Second KO | KEGG Genes ID | GHOSTX Score |
|---|---|---|---|---|---|---|
| Pvu9g1645 | - | - | gmx:100793074 | 1569.29 |